Navidea Biopharmaceuticals Inc (NAVB)
0.0368
-0.01
(-16.36%)
USD |
OTCM |
Apr 23, 15:47
Navidea Biopharmaceuticals Free Cash Flow (Quarterly): -10.27M for Sept. 30, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -10.27M |
| June 30, 2023 | 4.625M |
| March 31, 2023 | -1.762M |
| December 31, 2022 | -2.505M |
| September 30, 2022 | -1.937M |
| June 30, 2022 | -2.260M |
| March 31, 2022 | -2.674M |
| December 31, 2021 | -2.818M |
| September 30, 2021 | -2.146M |
| June 30, 2021 | -2.454M |
| March 31, 2021 | -3.13M |
| December 31, 2020 | -2.639M |
| September 30, 2020 | -2.839M |
| June 30, 2020 | -2.094M |
| March 31, 2020 | -1.016M |
| December 31, 2019 | -2.733M |
| September 30, 2019 | -2.343M |
| June 30, 2019 | -2.113M |
| March 31, 2019 | -2.165M |
| December 31, 2018 | -2.154M |
| September 30, 2018 | -1.903M |
| June 30, 2018 | 10.55M |
| March 31, 2018 | -2.260M |
| December 31, 2017 | -1.964M |
| September 30, 2017 | -0.9697M |
| Date | Value |
|---|---|
| June 30, 2017 | -5.675M |
| March 31, 2017 | 67.66M |
| December 31, 2016 | 2.258M |
| September 30, 2016 | 2.656M |
| June 30, 2016 | 0.3229M |
| March 31, 2016 | -1.682M |
| December 31, 2015 | -4.204M |
| September 30, 2015 | -4.109M |
| June 30, 2015 | -6.715M |
| March 31, 2015 | -4.115M |
| December 31, 2014 | -4.854M |
| September 30, 2014 | -6.749M |
| June 30, 2014 | -8.550M |
| March 31, 2014 | -10.16M |
| December 31, 2013 | -11.66M |
| September 30, 2013 | -9.808M |
| June 30, 2013 | -7.688M |
| March 31, 2013 | -7.753M |
| December 31, 2012 | -7.367M |
| September 30, 2012 | -5.309M |
| June 30, 2012 | -5.187M |
| March 31, 2012 | -6.732M |
| December 31, 2011 | -9.803M |
| September 30, 2011 | -3.774M |
| June 30, 2011 | -0.8186M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-10.27M
Minimum
Sep 2023
4.625M
Maximum
Jun 2023
-2.395M
Average
-2.398M
Median
Free Cash Flow (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -9.097M |
| Electromed Inc | 3.384M |
| Xtant Medical Holdings Inc | -1.278M |
| Asensus Surgical Inc | -13.45M |
| Senseonics Holdings Inc | -15.24M |